Chairs: Dr Stefan Unger (Edinburgh, United Kingdom), Dr Alexander Kiefer (Regensburg, Germany)

Speakers: Dr Laura Garriga Grimau (Barcelona, Spain), Prof. Michal Shteinberg (Haifa, Israel)

Fees: Free for ERS members / €10 for non-members
Find out more about becoming a member

Please note: non-members will need to create a free myERS account to register for this activity.

Overview

Childhood bronchiectasis remains under-recognised and variably treated, particularly outside specialised paediatric pulmonology centres. Definition and antibiotic management of exacerbations differs widely across regions, and there is uncertainty regarding duration, route, and choice of antibiotics. In addition, recent advances in bronchiectasis treatment and newly approved drugs-primarily studied in adults raise important questions about applicability in adolescents and older children. There is also a clear need to address management strategies in low-resource settings and to clarify the role of primary care in early recognition, initiation of treatment, and timely referral.

Educational aims:

• To provide an up-to-date, evidence-based overview of antibiotic treatment of exacerbations in childhood bronchiectasis.
• To bridge paediatric and adult perspectives, including recent guideline updates and newly approved therapies.
• To highlight practical management strategies applicable across different healthcare settings, including low-resource environments.
• To support primary care clinicians in recognising bronchiectasis, managing exacerbations, and identifying referral thresholds.

Topics:

• Definition and diagnosis of childhood bronchiectasis
• Principles of antibiotic treatment of exacerbations in children
• Duration, route, and selection of antibiotics
• Transition from paediatric to adult care and alignment with adult guidelines
• Role of newly approved bronchiectasis therapies in adolescents (≥12 years)
• Management strategies in low-resource settings
• Role of primary care and referral pathways
• Patient and family perspective on treatment burden and outcomes

Format

One-hour webinar structured as follows:

• Opening remarks - Introduction by Chairs (2 min)
• Presentation 1: Living with childhood bronchiectasis: the patient and family perspective - Patient Representative (14 min)
• Presentation 2: Childhood bronchiectasis: definition, diagnosis and antibiotic treatment of exacerbations - Laura Garriga Grimau (14 min)
• Presentation 3: - Adult bronchiectasis guidelines and new therapies: relevance for adolescents and transition care - Michal Shteinberg (14 min)
• Panel discussion & audience interaction (cases, polls, Q&A) - Moderated by Chairs (15 min)
• Wrap-up (1 min)

Learning outcomes

Following this webinar, participants will be able to:

• Define childhood bronchiectasis and recognise common clinical presentations
• Apply evidence-based principles for antibiotic treatment of exacerbations in children
• Differentiate between paediatric and adult guideline recommendations and understand their overlap
• Evaluate the role of newly approved bronchiectasis therapies in adolescents
• Identify appropriate management strategies in low-resource settings
• Recognise when referral to paediatric pulmonology or hospital care is indicated

CME credit

An application for accreditation of this webinar has been made to the European Board for Accreditation in Pneumology (EBAP) for 1 CME credit per 1-hour attendance. If accredited, the CME credit will be granted upon attendance of at least 60 minutes during the live webinar only.

What is a webinar?

A webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting. During the webinar, you will be asked to share your opinion on issues related to the topic using interactive polls.

All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.

Login guidelines

More information will be communicated in due course.

• Please log in to the webinar 20 minutes before it is scheduled to commence. If you have any technical difficulties whilst trying to log in or during the session please contact e-learning@ersnet.org.
• Check Central European Time.
• To achieve the best quality, we recommend to avoid downloading anything from the internet during your connection to the lecture and stopping all other programmes.
• Please also ensure that your audio settings are not set to mute and adjust the volume to a comfortable level.